Therefore, in a kinetic study, we cultivated primary CLL cells with 4 μg EVs from Lyn-proficient, Lyn-deficient HS-5 cells or without addition of vesicles as a control (Figure 5B). The gene discussed is LYN; the disease is B-cell chronic lymphocytic leukemia.